Studies related to Symptoms of Autism and L-Carnitine

A Prospective Double-blind, Randomized Clinical Trial Of Levocarnitine To Treat Autism Spectrum Disorders

Effect Decrease
Trial Design Double blind
Trial Length n/a
Number of Subjects 30
Sex n/a
Notes for this study:
L-carnitine, at 50mg per kilogram bodyweight, was associated with improvements on three rating scales of Autism Symptoms (CARS, ATEC, and CGI). Treatment was well tolerated, and severity of symptoms was inversely correlated with serum carnitine levels.